SCHWEIBERT LESSMANN jointly with Kirkland & Ellis advises Bain Capital and Cinven in Public Tender Offer to Stada

Jointly with Kirkland & Ellis International LLP Schweibert Leßmann has advised private equity investors Bain Capital and Cinven in a joint public takeover offer for German pharmaceutical company Stada Arzneimittel AG (Stada). Bain Capital and Cinven offer EUR 65.28 plus a dividend of EUR 0.72 per Stada share. The executive board and the supervisory board of Stada announced that they have decided to support the offer by Bain Capital and Cinven.

With a total value of approximately EUR 5.3 billion, the takeover is likely to be the largest private equity transaction ever realized in the German market.

Please rotate Device to Portrait.